EQUILLIUM, INC. Operating Income
EQUILLIUM, INC. (EQ) reported Operating Income of -$5.16 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-13
- EQUILLIUM, INC. operating income (loss) for the quarter ending 2026-06-30 was -$5.16M.
- EQUILLIUM, INC. operating income (loss) for the quarter ending 2026-03-31 was -$5.61M.
- EQUILLIUM, INC. operating income (loss) for the quarter ending 2025-12-31 was -$3.96M.
- EQUILLIUM, INC. operating income (loss) for the quarter ending 2025-09-30 was -$4.58M.
- EQUILLIUM, INC. operating income (loss) for fiscal 2025 was -$23.63M.
- EQUILLIUM, INC. operating income (loss) for fiscal 2024 was -$8.27M.
- EQUILLIUM, INC. operating income (loss) for fiscal 2023 was -$14.52M.
- EQUILLIUM, INC. operating income (loss) for fiscal 2022 was -$62.08M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 7 month | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 10 month | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$5.16M 10-Q · filed 2026-08-13 | -$10.77M 10-Q · filed 2026-08-13 | -$14.73M derived: sum of 3 quarters · filed 2026-08-13 | -$19.30M derived: sum of 4 quarters · filed 2026-08-13 | |||||
| 2026-03-31 | -$5.61M 10-Q · filed 2026-05-13 | -$9.57M derived: sum of 2 quarters · filed 2026-05-13 | -$14.15M derived: sum of 3 quarters · filed 2026-05-13 | -$20.38M derived: sum of 4 quarters · filed 2026-08-13 | |||||
| 2025-12-31 | -$3.96M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$8.54M derived: sum of 2 quarters · filed 2026-03-25 | -$14.77M derived: sum of 3 quarters · filed 2026-08-13 | -$23.63M 10-K · filed 2026-03-25 | |||||
| 2025-09-30 | -$4.58M 10-Q · filed 2025-11-13 | -$10.80M derived: sum of 2 quarters · filed 2026-08-13 | -$19.67M 10-Q · filed 2025-11-13 | -$24.37M derived: sum of 4 quarters · filed 2026-08-13 | |||||
| 2025-06-30 | -$6.23M 10-Q · filed 2026-08-13 | -$15.10M 10-Q · filed 2026-08-13 | -$19.80M derived: sum of 3 quarters · filed 2026-08-13 | -$20.48M derived: sum of 4 quarters · filed 2026-08-13 | |||||
| 2025-03-31 | -$8.87M 10-Q · filed 2026-05-13 | -$13.57M derived: sum of 2 quarters · filed 2026-05-13 | -$14.25M derived: sum of 3 quarters · filed 2026-05-13 | -$14.35M derived: sum of 4 quarters · filed 2026-05-13 | |||||
| 2024-12-31 | -$4.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$5.38M derived: sum of 2 quarters · filed 2026-03-25 | -$5.48M derived: sum of 3 quarters · filed 2026-03-25 | -$8.27M 10-K · filed 2026-03-25 | |||||
| 2024-09-30 | -$679.00K 10-Q · filed 2025-11-13 | -$779.00K derived: sum of 2 quarters · filed 2025-11-13 | -$3.57M 10-Q · filed 2025-11-13 | -$6.77M derived: sum of 4 quarters · filed 2025-11-13 | |||||
| 2024-06-30 | -$100.00K 10-Q · filed 2025-08-14 | -$2.89M 10-Q · filed 2025-08-14 | -$6.09M derived: sum of 3 quarters · filed 2025-08-14 | -$9.71M derived: sum of 4 quarters · filed 2025-08-14 | |||||
| 2024-03-31 | -$2.79M 10-Q · filed 2025-05-14 | -$5.99M derived: sum of 2 quarters · filed 2025-05-14 | -$9.61M derived: sum of 3 quarters · filed 2025-05-14 | -$13.21M derived: sum of 4 quarters · filed 2025-05-14 | |||||
| 2023-12-31 | -$3.20M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | -$6.82M derived: sum of 2 quarters · filed 2025-03-27 | -$10.41M derived: sum of 3 quarters · filed 2025-03-27 | -$14.52M 10-K · filed 2025-03-27 | |||||
| 2023-09-30 | -$3.62M 10-Q · filed 2024-11-13 | -$7.21M derived: sum of 2 quarters · filed 2024-11-13 | -$11.32M 10-Q · filed 2024-11-13 | -$9.28M derived: sum of 4 quarters · filed 2024-11-13 | |||||
| 2023-06-30 | -$3.59M 10-Q · filed 2024-08-08 | -$7.70M 10-Q · filed 2024-08-08 | -$5.66M derived: sum of 3 quarters · filed 2024-08-08 | -$18.89M derived: sum of 4 quarters · filed 2024-08-08 | |||||
| 2023-03-31 | -$4.11M 10-Q · filed 2024-05-09 | -$2.07M derived: sum of 2 quarters · filed 2024-05-09 | -$15.30M derived: sum of 3 quarters · filed 2024-05-09 | -$28.86M derived: sum of 4 quarters · filed 2024-05-09 | |||||
| 2022-12-31 | $2.04M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | -$11.20M derived: sum of 2 quarters · filed 2024-03-25 | -$24.75M derived: sum of 3 quarters · filed 2024-03-25 | -$62.08M 10-K · filed 2024-03-25 | |||||
| 2022-09-30 | -$13.24M 10-Q · filed 2023-11-08 | -$26.79M derived: sum of 2 quarters · filed 2023-11-08 | -$64.12M 10-Q · filed 2023-11-08 | -$74.50M derived: sum of 4 quarters · filed 2023-11-08 | |||||
| 2022-06-30 | -$13.55M 10-Q · filed 2023-08-09 | -$50.88M 10-Q · filed 2023-08-09 | -$61.27M derived: sum of 3 quarters · filed 2023-08-09 | -$71.13M derived: sum of 4 quarters · filed 2023-08-09 | |||||
| 2022-03-31 | -$37.33M 10-Q · filed 2023-05-11 | -$47.72M derived: sum of 2 quarters · filed 2023-05-11 | -$57.58M derived: sum of 3 quarters · filed 2023-05-11 | -$66.42M derived: sum of 4 quarters · filed 2023-05-11 | |||||
| 2021-12-31 | -$10.39M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | -$20.25M derived: sum of 2 quarters · filed 2023-03-23 | -$29.09M derived: sum of 3 quarters · filed 2023-03-23 | -$37.79M 10-K · filed 2023-03-23 | |||||
| 2021-09-30 | -$9.86M 10-Q · filed 2022-11-14 | -$18.70M derived: sum of 2 quarters · filed 2022-11-14 | -$27.40M 10-Q · filed 2022-11-14 | -$36.37M derived: sum of 4 quarters · filed 2022-11-14 | |||||
| 2021-06-30 | -$8.84M 10-Q · filed 2022-08-15 | -$17.54M 10-Q · filed 2022-08-15 | -$26.51M derived: sum of 3 quarters · filed 2022-08-15 | -$33.02M derived: sum of 4 quarters · filed 2022-08-15 | |||||
| 2021-03-31 | -$8.70M 10-Q · filed 2022-05-12 | -$17.66M derived: sum of 2 quarters · filed 2022-05-12 | -$24.18M derived: sum of 3 quarters · filed 2022-05-12 | -$30.79M derived: sum of 4 quarters · filed 2022-05-12 | |||||
| 2020-12-31 | -$8.97M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | -$15.49M derived: sum of 2 quarters · filed 2022-03-23 | -$22.10M derived: sum of 3 quarters · filed 2022-03-23 | -$29.55M 10-K · filed 2022-03-23 | |||||
| 2020-09-30 | -$6.52M 10-Q · filed 2021-11-10 | -$13.13M derived: sum of 2 quarters · filed 2021-11-10 | -$20.58M 10-Q · filed 2021-11-10 | -$28.19M derived: sum of 4 quarters · filed 2021-11-10 | |||||
| 2020-06-30 | -$6.61M 10-Q · filed 2021-08-10 | -$14.06M 10-Q · filed 2021-08-10 | -$21.68M derived: sum of 3 quarters · filed 2021-08-10 | -$28.00M derived: sum of 4 quarters · filed 2021-08-10 | |||||
| 2020-03-31 | -$7.45M 10-Q · filed 2021-05-13 | -$15.07M derived: sum of 2 quarters · filed 2021-05-13 | -$21.39M derived: sum of 3 quarters · filed 2021-05-13 | -$27.83M derived: sum of 4 quarters · filed 2021-05-13 | |||||
| 2019-12-31 | -$7.62M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-24 | -$13.94M derived: sum of 2 quarters · filed 2021-03-24 | -$20.38M derived: sum of 3 quarters · filed 2021-03-24 | -$26.73M 10-K · filed 2021-03-24 | |||||
| 2019-09-30 | -$6.32M 10-Q · filed 2020-11-10 | -$12.76M derived: sum of 2 quarters · filed 2020-11-10 | -$19.11M 10-Q · filed 2020-11-10 | -$23.34M derived: sum of 4 quarters · filed 2020-11-10 | |||||
| 2019-06-30 | -$6.44M 10-Q · filed 2020-08-12 | -$12.79M 10-Q · filed 2020-08-12 | -$17.01M derived: sum of 3 quarters · filed 2020-08-12 | -$19.24M derived: sum of 4 quarters · filed 2020-08-12 | |||||
| 2019-03-31 | -$6.35M 10-Q · filed 2020-05-13 | -$10.57M derived: sum of 2 quarters · filed 2020-05-13 | -$12.80M derived: sum of 3 quarters · filed 2020-05-13 | -$13.93M derived: sum of 4 quarters · filed 2020-05-13 | |||||
| 2018-12-31 | -$4.23M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | -$6.45M derived: sum of 2 quarters · filed 2020-03-26 | -$7.58M derived: sum of 3 quarters · filed 2020-03-26 | -$8.62M 10-K · filed 2020-03-26 | -$8.62M 10-K · filed 2019-03-27 | ||||
| 2018-09-30 | -$2.23M 10-Q · filed 2019-11-12 | -$2.23M 10-Q · filed 2018-11-15 | -$3.35M derived: sum of 2 quarters · filed 2019-11-12 | -$4.39M 10-Q · filed 2019-11-12 | -$4.39M 10-Q · filed 2018-11-15 | ||||
| 2018-06-30 | -$1.13M 10-Q · filed 2019-08-12 | -$2.16M 10-Q · filed 2019-08-12 | |||||||
| 2018-03-31 | -$1.04M 10-Q · filed 2019-05-13 | ||||||||
| 2017-12-31 | -$1.71M 10-K · filed 2019-03-27 | ||||||||
| 2017-09-30 | -$83.71K 10-Q · filed 2018-11-15 | -$1.07M 10-Q · filed 2018-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |